Thank you for your interest in Novavax’s 2024 COVID-19 vaccine.
Please fill out the form below to place your initial order.
Click here to access the Customer Notice
The Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (the "COVID-19 Vaccine") has not been approved or licensed by the FDA, but has been authorized for emergency use by the FDA, under an Emergency Use Authorization (“EUA”) to prevent Coronavirus Disease 2019 (COVID-19) for use in individuals 12 years of age and older.